Latarjet Procedure: Comparative Outcomes Study of Arthroscopic Versus Mini-open Approach With Minimum 2-year Follow-up

Sponsor
Hospital Ambroise Paré Paris (Other)
Overall Status
Completed
CT.gov ID
NCT02505932
Collaborator
(none)
58
2
35
29
0.8

Study Details

Study Description

Brief Summary

To date, use of arthroscopic procedure to perform Latarjet procedure is still technically demanding. The benefits of arthroscopic procedure need to be evaluated compared to the mini-invasive approach. The aim of this study was to assess postoperative pain during the first week, and the positioning of coracoid bone block at the anterior aspect of the glenoid. At minimum 2 years follow-up, the recurrence of shoulder instability and functional evaluation of patients according to the Western Ontario Score Index (WOSI) were assessed.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Arthroscopic Latarjet procedure
  • Procedure: Mini-open Latarjet procedure

Detailed Description

This prospective comparative study was performed at two centers in 2012. Each center performed one procedure so this study was observational. All patients with a chronic anterior instability requiring bone grafting (Instability Severity Index Score>3) were included. The Latarjet procedure was performed by mini-open approach (set Arthrex, Naples, FL) in the first group, and by arthroscopic approach (set Depuy-Mitek, Raynham, MA) in the second group. The analgesic postoperative protocol was standardized (paracetamol, non-steroidal anti-inflammatory, tramadol).

Study Design

Study Type:
Observational
Actual Enrollment :
58 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Latarjet Procedure: Comparative Outcomes Study of Arthroscopic Versus Mini-open Approach With Minimum 2-year Follow-up
Study Start Date :
Jan 1, 2012
Actual Primary Completion Date :
Jan 1, 2014
Actual Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Arthroscopic Latarjet procedure

arthroscopic approach (set Depuy-Mitek, Raynham, MA)

Procedure: Arthroscopic Latarjet procedure
arthroscopic approach (set Depuy-Mitek, Raynham, MA)

Mini-open Latarjet procedure

mini-open approach (set Arthrex, Naples, FL)

Procedure: Mini-open Latarjet procedure
mini-open approach (set Arthrex, Naples, FL)

Outcome Measures

Primary Outcome Measures

  1. Average postoperative shoulder's pain on visual analogic scale from 0 (no pain) to 10 (maximum pain) [Average during the first week]

Secondary Outcome Measures

  1. Mean daily pain on visual analogic scale from 0 (no pain) to 10 (maximum pain) [Daily from day1 to day7]

  2. analgesic consumption (Number of pills) [Daily from day1 to day7]

  3. presence of postoperative discomfort symptoms (yes/no) [Daily from day1 to day7]

    The presence (yes/no) of incision site pain, nausea, vomiting, vertigo, anxiety

  4. coracoid bone block position to the anterior aspect of the glenoid on the anterior-posterior and the lateral X-ray and on CT-scan [Between 3 to 6 months follow-up]

  5. Recurrence rate of shoulder instability (number of recurrence/total number of patients) [2-year minimal follow-up]

  6. Functional evaluation of patients [2-year minimal follow-up]

    Western Ontario Score Index (WOSI)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • chronic anterior instability requiring bone grafting (Instability Severity Index Score>3)
Exclusion Criteria:
  • Patient refusal

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Ambroise Paré Paris Boulogne-Billancourt France 92000
2 Clinique des Maussins Paris France

Sponsors and Collaborators

  • Hospital Ambroise Paré Paris

Investigators

  • Study Director: Shahnaz Klouche, MD, Hospital Ambroise Paré Paris

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shahnaz Klouche, MD, Physician responsible of clinical research, Hospital Ambroise Paré Paris
ClinicalTrials.gov Identifier:
NCT02505932
Other Study ID Numbers:
  • APR012012
First Posted:
Jul 22, 2015
Last Update Posted:
Jul 22, 2015
Last Verified:
Jul 1, 2015
Keywords provided by Shahnaz Klouche, MD, Physician responsible of clinical research, Hospital Ambroise Paré Paris
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 22, 2015